False Activations for ST-Segment Elevation Myocardial Infarction.

Autor:	Lange DC; Division of Cardiology, Cedars-Sinai Heart Institute, Los Angeles, CA, USA., Rokos IC; Department of Emergency Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Garvey JL; Department of Emergency Medicine, Carolinas Medical Center, Charlotte, NC, USA., Larson DM; Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, MN, USA., Henry TD; Division of Cardiology, Cedars-Sinai Heart Institute, Los Angeles, CA, USA. Electronic address: henryt@cshs.org.
Jazyk:	angličtina
Zdroj:	Interventional cardiology clinics [Interv Cardiol Clin] 2016 Oct; Vol. 5 (4), pp. 451-469. Date of Electronic Publication: 2016 Aug 05.
DOI:	10.1016/j.iccl.2016.06.002
Abstrakt:	First-medical-contact-to-device (FMC2D) times have improved over the past decade, as have clinical outcomes for patients presenting with ST-elevation myocardial infarction (STEMI). However, with improvements in FMC2D times, false activation of the cardiac catheterization laboratory (CCL) has become a challenging problem. The authors define false activation as any patient who does not warrant emergent coronary angiography for STEMI. In addition to clinical outcome measures for these patients, STEMI systems should collect data regarding the total number of CCL activations, the total number of emergency coronary angiograms, and the number revascularization procedures performed. (Copyright © 2016 Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu